You can access the distribution details by navigating to My Print Books(POD) > Distribution
Cancer treatment has entered an era of precision medicine, where advances in molecular diagnostics, targeted therapies, immunotherapy, and multidisciplinary care are transforming patient outcomes. Cancer Insights – Volume II: Clinical Oncology provides a comprehensive and evidence-based exploration of the principles and practices of modern cancer management. This volume covers the core aspects of clinical oncology, including medical oncology, surgical oncology, pediatric oncology, hematologic malignancies, palliative and supportive care, cancer survivorship, and quality of life. It also discusses precision oncology, emerging therapeutic strategies, and the integration of personalized medicine into routine clinical practice. Special emphasis is placed on multidisciplinary cancer care, enabling readers to understand the collaborative approach required for optimal diagnosis, treatment, rehabilitation, and long-term follow-up of patients with cancer. Written by experts from diverse disciplines, the chapters combine current scientific evidence with practical clinical perspectives, making complex concepts accessible and relevant. The content is enriched with recent advances, evidence-based recommendations, and contemporary developments that reflect the rapidly evolving landscape of oncology. Designed for undergraduate and postgraduate students, researchers, medical practitioners, nursing and allied health professionals, and educators, Cancer Insights – Volume II: Clinical Oncology serves as a valuable academic and clinical resource for understanding the diagnosis, treatment, supportive care, and survivorship of individuals affected by cancer. From precision medicine to compassionate patient care, this volume offers a comprehensive guide to the science and practice of contemporary clinical oncology.
Currently there are no reviews available for this book.
Be the first one to write a review for the book Cancer Insights Volume 2 Clinical Oncology.